We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Purpose
This guidance explains the restrictions on advertising to substances included in Schedule 4 (prescription-only medicines) or Schedule 8 (controlled drugs) to the Poisons Standard or goods containing such substances.
The same advertising rules apply to substances included in Schedule 3 (pharmacist only medicines) or goods containing such substances, unless included in Appendix H1 to the Poisons Standard. For simplicity, references in this guidance to prescription medicines include substances in schedules 3, 4 and 8.
This guidance does not cover advertising requirements for vaping goods. See Vapes: advertising and promotion for information about the restrictions around advertising and promotion of vapes.
The Therapeutic Goods Act 1989 (the Act) prohibits the advertising of prescription medicines to the public, except in very limited circumstances.
Prescription medicines carry higher risks than other medicines available without a prescription. Patients should make informed decisions about which treatments are right for them in consultation with a qualified health professional. A consultation provides the most reliable way to determine whether a prescription medicine is appropriate for an individual.
Advertising of prescription medicines to the public can create inappropriate demand and undermine the relationship between patients and their treating health practitioners.
This guidance helps businesses involved with prescription medicines, including sponsors, health services and relevant third parties, to ensure they do not unlawfully advertise these medicines to the public.
For background information, see Advertising basics.
This information is provided for guidance only and is not intended to address every aspect of the relevant legislation or all advertising scenarios.
You should seek independent legal advice to ensure you comply with all legislative requirements.